Viatris Inc
VTRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001792044
No open-market purchases or sales by Viatris Inc insiders were filed in the last 90 days; 1,032 institutions reported holding it in 13F filings for Q2 2026, worth $16.6B in total; Greenlight Capital is the only superinvestor holding it.
Q1 2022 vs. Q4 2021
How the institutions holding Viatris Inc changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 1,073 | 9 | 1,024 | −40 |
| Shares | 894.0M | 413.8K | 888.4M | −5.17M (−0.6%) |
| Value | $12.1B | $5.60M | $9.67B | −$2.43B (−20.1%) |
9 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (100)
Institutions that held Viatris Inc at the end of Q1 2022 but not at the end of Q4 2021.
Sold out (140)
Institutions that held Viatris Inc at the end of Q4 2021 and filed for Q1 2022 without it.
Showing the largest 100 of 140 by value.
Not filed for Q1 2022 yet (9)
Institutions that held Viatris Inc at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Pineno Levin & Ford Asset Management, Inc. | 179,750 | $2.43M |
| Truehand, Inc | 122,051 | $1.65M |
| NEXT Financial Group, Inc | 75,982 | $1.03M |
| Harbour Investments, Inc. | 13,912 | $188.0K |
| Carroll Financial Associates, Inc. | 10,113 | $138.0K |
| Crescent Capital Consulting, LLC | 6,169 | $84.0K |
| Reilly Financial Advisors, LLC | 5,020 | $68.0K |
| Bell Investment Advisors, Inc | 732 | $10.0K |
| Castle Financial & Retirement Planning Associates, Inc. | 104 | $2.00K |